Table 1.
Demographic and clinicopathologic characteristics of 56 cystectomy patients
| Demographic and Pathologic Features | |
|---|---|
| Age (y) | |
| Median (range) | 67.4 (34.8–89.2) |
| Mean (SD) | 65.8 (11.9) |
| Gender, n (%) | |
| Male | 45/56 (80.4) |
| Female | 11/56 (19.6) |
| Ethnicity, n (%) | |
| Caucasian | 51/56 (91) |
| African American | 5/56 (9) |
| pT category, n (%) | |
| pTa | 2/56 (3.6) |
| pTis | 4/56 (7.1) |
| pT1 | 5/56 (8.9) |
| pT2 | 17/56 (30.4) |
| pT3 | 22/56 (39.3) |
| pT4 | 6/56 (10.7) |
| Lymph node metastasis, n (%) | |
| No | 39/49 (79.6) |
| Yes | 10/49 (20.4) |
| Lymphovascular invasion, n (%) | |
| No | 38 (67.9) |
| Yes | 18 (32.1) |
| Treatment | |
| Neoadjuvant radiotherapy, n (%) | |
| No | 53/55 (96.4) |
| Yes | 2/55 (3.6) |
| Neoadjuvant chemotherapy, n (%) | |
| No | 50/55 (90.9) |
| Yes | 5/55 (9.1) |
| Intravesical therapy, n (%) | |
| No | 26/52 (50) |
| Yes | 26/52 (50) |
| Adjuvant radiotherapy, n (%) | |
| No | 50/55 (90.9) |
| Yes | 5/55 (9.1) |
| Adjuvant chemotherapy, n (%) | |
| No | 32/55 (58.2) |
| Yes | 23/55 (41.8) |
SD, standard deviation.